Literature DB >> 32059873

Induction of antitumor immunity in mice by the combination of nanoparticle-based photothermolysis and anti-PD-1 checkpoint inhibition.

Qizhen Cao1, Wanqin Wang1, Min Zhou1, Qian Huang1, Xiaoxia Wen1, Jun Zhao1, Sixiang Shi1, Ku Geng1, Fenge Li2, Hiroto Hatakeyama3, Chunyu Xu2, David Piwnica-Worms1, Weiyi Peng2, Dapeng Zhou2, Anil K Sood3, Chun Li4.   

Abstract

Generation of durable tumor-specific immune response without isolation and expansion of dendritic cells or T cells ex vivo remains a challenge. In this study, we investigated the impact of nanoparticle-mediated photothermolysis in combination with checkpoint inhibition on the induction of systemic antitumor immunity. Photothermolysis based on near-infrared light-absorbing copper sulfide nanoparticles and 15-ns laser pulses combined with the immune checkpoint inhibitor anti-PD-1 antibody (αPD-1) increased tumor infiltration by antigen-presenting cells and CD8-positive T lymphocytes in the B16-OVA mouse model. Moreover, combined photothermolysis, polymeric conjugate of the Toll-like receptor 9 agonist CpG, and αPD-1 significantly prolonged mouse survival after re-inoculation of tumor cells at a distant site compared to individual treatments alone in the poorly immunogenic syngeneic ID8-ip1-Luc ovarian tumor model. Thus, photothermolysis is a promising interventional technique that synergizes with Toll-like receptor 9 agonists and immune checkpoint inhibitors to enhance the abscopal effect in tumors.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Abscopal effect; Checkpoint inhibitor; CuS nanoparticle; Photothermolysis; Pulsed laser

Mesh:

Substances:

Year:  2020        PMID: 32059873      PMCID: PMC7181381          DOI: 10.1016/j.nano.2020.102169

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  34 in total

1.  Immune Checkpoint Blockade in Cancer Therapy: The 2015 Lasker-DeBakey Clinical Medical Research Award.

Authors:  James P Allison
Journal:  JAMA       Date:  2015-09-15       Impact factor: 56.272

2.  Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy.

Authors:  Laetitia Fend; Takahiro Yamazaki; Christelle Remy; Catherine Fahrner; Murielle Gantzer; Virginie Nourtier; Xavier Préville; Eric Quéméneur; Oliver Kepp; Julien Adam; Aurélien Marabelle; Jonathan M Pitt; Guido Kroemer; Laurence Zitvogel
Journal:  Cancer Res       Date:  2017-05-23       Impact factor: 12.701

3.  A chelator-free multifunctional [64Cu]CuS nanoparticle platform for simultaneous micro-PET/CT imaging and photothermal ablation therapy.

Authors:  Min Zhou; Rui Zhang; Miao Huang; Wei Lu; Shaoli Song; Marites P Melancon; Mei Tian; Dong Liang; Chun Li
Journal:  J Am Chem Soc       Date:  2010-11-03       Impact factor: 15.419

4.  Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma.

Authors:  Nienke van Rooij; Marit M van Buuren; Daisy Philips; Arno Velds; Mireille Toebes; Bianca Heemskerk; Laura J A van Dijk; Sam Behjati; Henk Hilkmann; Dris El Atmioui; Marja Nieuwland; Michael R Stratton; Ron M Kerkhoven; Can Kesmir; John B Haanen; Pia Kvistborg; Ton N Schumacher
Journal:  J Clin Oncol       Date:  2013-09-16       Impact factor: 44.544

5.  Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated.

Authors:  Sandra Demaria; Bruce Ng; Mary Louise Devitt; James S Babb; Noriko Kawashima; Leonard Liebes; Silvia C Formenti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-03-01       Impact factor: 7.038

6.  Modulating the tumor immune microenvironment as an ovarian cancer treatment strategy.

Authors:  Uciane K Scarlett; Jose R Conejo-Garcia
Journal:  Expert Rev Obstet Gynecol       Date:  2012-09-01

7.  Mechanisms of nanoparticle-mediated photomechanical cell damage.

Authors:  Sara Peeters; Michael Kitz; Stefan Preisser; Antoinette Wetterwald; Barbara Rothen-Rutishauser; George N Thalmann; Christina Brandenberger; Arthur Bailey; Martin Frenz
Journal:  Biomed Opt Express       Date:  2012-02-07       Impact factor: 3.732

8.  Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy.

Authors:  Qian Chen; Ligeng Xu; Chao Liang; Chao Wang; Rui Peng; Zhuang Liu
Journal:  Nat Commun       Date:  2016-10-21       Impact factor: 14.919

9.  Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines.

Authors:  Spencer D Martin; Scott D Brown; Darin A Wick; Julie S Nielsen; David R Kroeger; Kwame Twumasi-Boateng; Robert A Holt; Brad H Nelson
Journal:  PLoS One       Date:  2016-05-18       Impact factor: 3.240

10.  Fractional Laser Releases Tumor-Associated Antigens in Poorly Immunogenic Tumor and Induces Systemic Immunity.

Authors:  Masayoshi Kawakubo; Trevor J Cunningham; Shadmehr Demehri; Dieter Manstein
Journal:  Sci Rep       Date:  2017-10-06       Impact factor: 4.379

View more
  7 in total

Review 1.  Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology.

Authors:  Martha Sahylí Ortega Pijeira; Herlys Viltres; Jan Kozempel; Michal Sakmár; Martin Vlk; Derya İlem-Özdemir; Meliha Ekinci; Seshasai Srinivasan; Amin Reza Rajabzadeh; Eduardo Ricci-Junior; Luciana Magalhães Rebelo Alencar; Mohammed Al Qahtani; Ralph Santos-Oliveira
Journal:  EJNMMI Radiopharm Chem       Date:  2022-04-25

Review 2.  Targeting the PD-1/PD-L1 axis for cancer treatment: a review on nanotechnology.

Authors:  Tuan Hiep Tran; Thi Thu Phuong Tran
Journal:  R Soc Open Sci       Date:  2022-04-13       Impact factor: 2.963

3.  Red Light Phototherapy Using Light-Emitting Diodes Inhibits Melanoma Proliferation and Alters Tumor Microenvironments.

Authors:  Evan Austin; Alisen Huang; Jennifer Y Wang; Marc Cohen; Edward Heilman; Emanual Maverakis; Josef Michl; Jared Jagdeo
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

4.  Identification of cuprotosis-mediated subtypes, the development of a prognosis model, and influence immune microenvironment in hepatocellular carcinoma.

Authors:  Jingjing Xiao; Zhenhua Liu; Jinlong Wang; Shuaimin Zhang; Yi Zhang
Journal:  Front Oncol       Date:  2022-08-30       Impact factor: 5.738

Review 5.  Nanomedicine Strategies for Heating "Cold" Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC.

Authors:  Yuqi Yang; Tianjiao Zhao; Qiaohui Chen; Yumei Li; Zuoxiu Xiao; Yuting Xiang; Boyu Wang; Yige Qiu; Shiqi Tu; Yitian Jiang; Yayun Nan; Qiong Huang; Kelong Ai
Journal:  Adv Sci (Weinh)       Date:  2022-07-22       Impact factor: 17.521

Review 6.  Combining nanomedicine and immune checkpoint therapy for cancer immunotherapy.

Authors:  Christine E Boone; Lu Wang; Aayushma Gautam; Isabel G Newton; Nicole F Steinmetz
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2021-07-22

Review 7.  Tumor Targeted Nanocarriers for Immunotherapy.

Authors:  Alejandro Baeza
Journal:  Molecules       Date:  2020-03-26       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.